Targeted Therapy (Trastuzumab / Imatinib course) cost in South Korea (2026)
Targeted Therapy (Trastuzumab / Imatinib course) in South Korea starts from $7,850. Based on 8 hospital prices in our database. Your exact price depends on the hospital, room and implant.
- 14 days to full recovery
- 8 hospital prices
- 5 days visa processing
Prices are hospital price ranges from our database, not a final quote. How we check
Estimate your total cost
Choose your options. The price updates straight away.
Hospital package = typical price range from 8 hospital prices.
Room and implant choices use rough adjustments (est.). Meals at about $15 per person per day. Flights not included.
Get 3 real quotes for this estimateCost breakdown: what changes the price
Based on 8 hospital prices in South Korea.
Best hospitals for Targeted Therapy (Trastuzumab / Imatinib course) in South Korea
How we rankRanked by accreditation, patient rating and review count, then price.
-
1 Asan Medical CenterSeoul · ISO 9001 · JCI · KOIHA · ★ 4.8From$8,210from $8,210 21 doctors listed JCI accredited -
2 -
3 -
4 Gachon University Gil HospitalIncheonFrom$8,020from $8,020 12 doctors listed -
5 From$8,220from $8,220 14 doctors listed
Get the Targeted Therapy (Trastuzumab / Imatinib course) in South Korea cost & planning report
A free PDF built from today's listed prices. Keep it, print it or send it to your family on WhatsApp.
What's inside
- Prices by country, city and hospital, compared with home
- All-in trip budget: treatment, stay, food, visa
- Day-by-day timeline and recovery milestones
- Visa summary, preparation checklist and questions to ask
- Treatment (typical listed price) 87% $15,100
- Accommodation 7% $1,200
- Food 5% $800
- Local transport 1% $150
- Visa fees 1% $100
- Estimated total$17,300
Source: medcasts.com · prices as of May 2026
✓ Your report is ready
Download PDF Send to my family on WhatsApp Ask a coordinator on WhatsApp → Get a personal quote instead →Get a free second opinion in 48 hours.
Send your scans and reports. A senior specialist reviews them and replies in writing.
South Korea vs other countries
Typical hospital price per country, from 72 price records in the Medcasts database.
What a hospital quote usually includes
- Surgeon, anaesthesia and operating room
- Your hospital stay and nursing care
- Routine tests and medicines during the stay
- Free Medcasts coordinator, visa letter help and airport pickup arrangements
- Not included: flights and hotel after discharge
Every quote we send lists what is and isn't included, line by line.
Your recovery plan
- Day 1Infusion or first tablets in a day unit; fever, chills or rash can occur and are treated at once. You go home the same day.
- Weeks 1-4Tiredness, diarrhoea, swelling or nausea may appear. Blood tests check counts and liver function.
- Months 2-3First response assessment with scans or blood markers; the plan is confirmed or adjusted.
- Months 6 onwardsTreatment continues for the planned duration with regular heart checks, bloods and scans.
Medical visa for South Korea
South Korea issues the C-3-3 Medical Treatment visa — 90 days, single or multiple entry, issued through Korean consulates or via designated medical-tourism facilitators (KTO-certified agencies). For oncology or complex surgery requiring >90 days, the G-1-10 category offers longer stays. One family attendant visa (C-3-3-1) per patient is standard.
- 1Choose your hospital from your quotes
- 2We help you get the hospital's invitation letter
- 3Apply with your passport, photo and the letter
- 4Fly. Your coordinator arranges airport pickup
Visa processing time by destination
We send the hospital invitation letter within 24 hours of your decision. Check your visa
About Targeted Therapy (Trastuzumab / Imatinib course)
Targeted therapy uses drugs that act on specific proteins driving a cancer, such as trastuzumab for HER2-positive breast or gastric cancer and imatinib for chronic myeloid leukaemia or GIST. It is for patients whose tumour testing shows a matching target.
This is a course of medicine rather than an operation. Trastuzumab is given as an infusion or injection at a day-care unit, usually every three weeks, while imatinib is a tablet taken daily at home. Treatment may run for months or years, sometimes alongside chemotherapy, and the drug and schedule are chosen to match your tumour's test results.
Usually a good fit if
- Tumour or blood test confirming the specific target, such as HER2-positive disease or BCR-ABL-positive leukaemia.
- Adequate heart function for trastuzumab, and acceptable liver and kidney function.
- Willingness to keep regular blood tests, scans and heart checks for the duration.
- A cancer type for which the drug has an established role.
May need to wait if
- Target not confirmed by a reliable laboratory test.
- Significantly reduced heart pumping function, which may need cardiology review before trastuzumab.
- Pregnancy or plans to conceive, because these drugs can harm an unborn baby.
- Inability to take the drug consistently or to attend monitoring.
How to prepare
- Bring pathology and molecular reports (HER2, BCR-ABL, KIT or similar); the drug is only appropriate if the target is confirmed.
- Have a baseline heart assessment such as an echocardiogram if trastuzumab is planned, plus blood counts, liver and kidney tests.
- Give your doctor a full list of medicines and supplements, as imatinib interacts with several common drugs; change nothing without instruction.
- Agree a plan for how long you will stay abroad and how treatment will continue safely at home.
- Ask about a reliable supply of the same brand or biosimilar for the whole course.
Questions to ask your surgeon
- Which test confirmed my target, and was it done in an accredited laboratory?
- Is this the original drug or a biosimilar, and is the course length the same as in international guidelines?
- How will my heart, liver and blood counts be monitored, and how often?
- What side effects should prompt me to call urgently, and who answers from abroad?
- What happens if I miss doses or cannot get the drug at home?
- Should this be combined with chemotherapy, surgery or hormone therapy?
Red flags when comparing hospitals
- Prescribing a targeted drug without seeing target-test results.
- Selling a short 'course' as a complete treatment for a cancer that normally needs long-term or combined therapy.
- No heart monitoring plan when trastuzumab is used.
- Unclear drug origin, batch or storage, or refusal to name the brand.
Questions about Targeted Therapy (Trastuzumab / Imatinib course) in South Korea
How much does Targeted Therapy (Trastuzumab / Imatinib course) cost in South Korea in 2026?
Prices start from $7,850, based on 8 hospital prices in South Korea in our database. Your final price depends on the hospital, room type and implant; we send written quotes that list what is included.
Is Targeted Therapy (Trastuzumab / Imatinib course) cheaper in South Korea than in other countries?
South Korea ranks 5 of 9 destinations we compare for this procedure. The lowest typical price is in India at about $8,213.
How long does a medical visa for South Korea take?
C-3-3 Medical Treatment Visa: processing takes about 5 days and the visa is valid for 90 days. We help with the hospital invitation letter.
Is targeted therapy the same as chemotherapy?
No. It blocks a specific abnormality in cancer cells, so side effects differ, but it can still cause tiredness, heart effects or liver changes. Sometimes it is combined with chemotherapy.
How long will I need to take it?
It depends on the cancer: trastuzumab is often given for about a year in early breast cancer, whereas imatinib may be continued for years. Your oncologist sets the duration.
Can I continue it after returning home?
Often yes, if the drug is available and a local oncologist agrees to supervise. Arrange this before you travel.
Do I need a heart check?
For trastuzumab, yes, before and during treatment. Imatinib needs mainly blood and liver monitoring.